References
- Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157–160.
- *van Doremalen N, Bushmaker T, Morris DH. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020;382(16):1564–1567. .
- *Arons MM, Hatfield KM, Reddy SC. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. N Engl J Med. 2020;382(22):2081–2090. .
- COVID-19 significantly impacts health services for noncommunicable diseases [Internet]. [ cited 2020 Aug 5]. Available from: https://www.who.int/news-room/detail/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.
- 1910.120 App B - General description and discussion of the levels of protection and protective gear. | Occupational Safety and Health Administration [Internet]. [ cited 2020 Jul 22]. Available from: https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.120AppB.
- US EPA O. Personal Protective Equipment [Internet]. US EPA. 2013 [ cited 2020 Jul 22]. Available from: https://www.epa.gov/emergency-response/personal-protective-equipment.
- CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Jul 22]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/using-ppe.html.
- National Infection Prevention and Control Manual: Appendix 16 - Best Practice - Aide memoire for levels of Personal Protective Equipment (PPE) for Healthcare Workers when providing patient care [Internet]. [ cited 2020 Jul 22]. Available from: http://www.nipcm.hps.scot.nhs.uk/appendices/appendix-16-best-practice-aide-memoire-for-levels-of-personal-protective-equipment-ppe-for-healthcare-workers-when-providing-patient-care/.
- Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic | NEJM [Internet]. [ cited 2020 Jul 22]. Available from: https://www.nejm.org/doi/full/10.1056/NEJMp2006141.
- Shortage of personal protective equipment endangering health workers worldwide [Internet]. [ cited 2020 Jul 22]. Available from: https://www.who.int/news-room/detail/03-03-2020-shortage-of-personal-protective-equipment-endangering-health-workers-worldwide.
- Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages [Internet]. WHO; 2020 [ cited 2020 Jul 9]. Available from: https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages.
- CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Jul 22]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html.
- Directorate General of Health Services M of H and FW Govt of India. Novel Coronavirus Disease 2019 (COVID-19): additional guidelines on rational use of Personal Protective Equipment (setting approach for Health functionaries working in non-COVID areas) [Internet]. [ cited 2020 Jul 6]. Available from: https://www.mohfw.gov.in/pdf/AdditionalguidelinesonrationaluseofPersonalProtectiveEquipmentsettingapproachforHealthfunctionariesworkinginnonCOVIDareas.pdf.
- Tirupathi R, Bharathidasan K, Palabindala V. Comprehensive review of mask utility and challenges during the COVID-19 pandemic. :7.
- Document - WHO Interim Guidance: Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages [Internet]. [ cited 2020 Jul 22]. Available from: https://data2.unhcr.org/en/documents/details/75543.
- Ministry of Health and Family Welfare DG of HS. Advisory for managing Healthcare workers working in COVID and Non-COVID areas of the hospital [Internet]. 2020 [ cited 2020 Jul 6]. Available from: https://www.mohfw.gov.in/pdf/AdvisoryformanagingHealthcareworkersworkinginCOVIDandNonCOVIDareasofthehospital.pdf.
- Indian Council of Medical Research (ICMR) M of H and FW Govt of India. Strategy for COVID-19 testing in India, Version 5. 2020;1.
- The Reproductive Number of COVID-19 Is Higher Compared to SARS Coronavirus - PubMed [Internet]. [ cited 2020 Jul 8]. Available from: https://pubmed.ncbi.nlm.nih.gov/32052846/.
- Ong SWX, Tan YK, Chia PY. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020;323(16):1610–1612.
- World Health Organization, Pandemic and Epidemic Diseases, World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care: WHO guidelines. [Internet]. 2014 [ cited 2020 Jul 8]. Available from: http://apps.who.int/iris/bitstream/10665/112656/1/9789241507134_eng.pdf?ua=1.
- Healthcare Facilities: Managing Operations During the COVID-19 Pandemic | CDC [Internet]. [ cited 2020 Jul 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-hcf.html.
- CDC. Framework for Healthcare Systems Providing Non-COVID-19 Clinical Care During the COVID-19 Pandemic [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Jul 8]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/framework-non-COVID-care.html.
- Ministry of Health and Family Welfare, Govt. of India. Essential services during COVID19 [Internet]. [ cited 2020 Jul 8]. Available from: https://www.mohfw.gov.in/pdf/EssentialservicesduringCOVID19updated0411201.pdf.
- CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Jul 22]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html.
- Guidance for Cleaning and Disinfecting Public Spaces, Workplaces, Businesses, Schools, and Homes.:9.
- CDC. Communities, Schools, Workplaces, & Events [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Nov 2]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/cleaning-disinfection.html.
- Heßling M, Hönes K, Vatter P. Ultraviolet irradiation doses for coronavirus inactivation – review and analysis of coronavirus photoinactivation studies. GMS Hyg Infect Control [Internet]. 2020 [ cited 2020 Nov 2]; 15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273323/.
- Mackenzie D. Ultraviolet Light Fights New Virus. Engineering (Beijing). 2020;6:851–853.
- Health C for D and R. UV Lights and Lamps: ultraviolet-C Radiation, Disinfection, and Coronavirus. FDA [Internet]. 2020 [ cited 2020 Nov 2]; Available from: https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/uv-lights-and-lamps-ultraviolet-c-radiation-disinfection-and-coronavirus.
- Torres AE, Lyons AB, Narla S. Ultraviolet-C and other methods of decontamination of filtering facepiece N-95 respirators during the COVID-19 pandemic. Photochem Photobiol Sci. 2020. DOI:10.1039/D0PP00131G
- European Respiratory Society G 9. 1. Lung function testing during COVID-19 pandemic and beyond [Internet]. [ cited 2020 Jul 9]. Available from: https://ers.app.box.com/s/zs1uu88wy51monr0ewd990itoz4tsn2h.
- US EPA. Moisture Control Guidance for Building Design, Construction and Maintenance [Internet]. US EPA. 2014 [ cited 2020 Jul 20]. Available from: https://www.epa.gov/iaq-schools/moisture-control-part-indoor-air-quality-design-tools-schools.
- Chin AWH, Chu JTS, Perera MRA. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe. 2020;1(1):e10.
- Bignamini E, Cazzato S, Cutrera R. Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic. Ital J Pediatr. 2020;46(1):68.
- Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations [Internet]. [ cited 2020 Jul 9]. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations.
- Wahidi MM, Shojaee S, Lamb CR. The Use of Bronchoscopy During the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report. CHEST [Internet]. 2020 [ cited 2020 Jul 4]; 0. Available from: https://journal.chestnet.org/article/S0012-3692(20)30850-3/abstract.
- Ora J, Puxeddu E, Cavalli F. Does bronchoscopy help the diagnosis in Covid-19 infection? European Respiratory Journal [Internet]. 2020 [ cited 2020 Jul 4]; Available from: https://erj.ersjournals.com/content/early/2020/06/08/13993003.01619–2020.
- CDC. Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Jul 24]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html.
- Pritchett MA, Oberg CL, Belanger A. Society for Advanced Bronchoscopy Consensus Statement and Guidelines for bronchoscopy and airway management amid the COVID-19 pandemic. J Thoracic Dis. 2020;12(5):1781–1798.
- Propositions pour la prise en charge anesthésique d’un patient suspect ou infecté à Coronavirus COVID-19 - La SFAR [Internet]. Société Française d’Anesthésie et de Réanimation. 2020 [ cited 2020 Jul 24]. Available from: https://sfar.org/propositions-pour-la-prise-en-charge-anesthesique-dun-patient-suspect-ou-infecte-a-coronavirus-covid–19/.
- Ferioli M, Cisternino C, Leo V. Protecting healthcare workers from SARS-CoV-2 infection: practical indications. Eur Respir Rev. 2020;29(155).
- Cheng VCC, Wong S-C, Chen JHK. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020;41(5):493–498.
- COVID-19: infection prevention and control (IPC) [Internet]. GOV.UK. [ cited 2020 Jul 8]. Available from: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control.
- COVID-19 personal protective equipment (PPE) [Internet]. GOV.UK. [ cited 2020 Jul 8]. Available from: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/covid-19-personal-protective-equipment-ppe.
- Amirav I, Newhouse MT. Transmission of coronavirus by nebulizer: a serious, underappreciated risk. CMAJ. 2020;192(13):E346.
- Minnesota Department of Health. Aerosol-Generating Procedures and Patients with Suspected or Confirmed COVID-19.:5.
- Ari A. Practical strategies for a safe and effective delivery of aerosolized medications to patients with COVID-19. Respir Med. 2020;167:105987.
- Lupia T, Scabini S, Mornese Pinna S. novel coronavirus (2019-nCoV) outbreak: A new challenge. J Glob Antimicrob Resist. 2020;2019(21):22–27.
- Mahdavinia M, Foster KJ, Jauregui E. Asthma prolongs intubation in COVID-19. The Journal of Allergy and Clinical Immunology: In Practice [Internet]. 2020 [ cited 2020 Jul 10]; Available from: http://www.sciencedirect.com/science/article/pii/S2213219820304761.
- Garg S. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2020 [ cited 2020 Jul 10]; 69. Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm.
- Assessment and management of adults with asthma during the covid-19 pandemic | The BMJ [Internet]. [ cited 2020 Jul 10]. Available from: https://www.bmj.com/content/369/bmj.m2092.
- Chhiba KD, Patel GB, Vu THT. Prevalence and characterization of asthma in hospitalized and non-hospitalized patients with COVID-19. Journal of Allergy and Clinical Immunology [Internet]. 2020 [ cited 2020 Jul 10]; Available from: http://www.sciencedirect.com/science/article/pii/S009167492030840X.
- Akenroye AT, Wood R, Keet C. Asthma, biologics, corticosteroids, and coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125(1):12–13.
- Global Initiative for Chronic Obstructive Lung Disease. GOLD COVID-19 Guidance [Internet]. Global Initiative for Chronic Obstructive Lung Disease - GOLD. [ cited 2020 Jul 10]. Available from: https://goldcopd.org/gold-covid-19-guidance/.
- COPD Foundation. Questions About How the Coronavirus Spreads? [Internet]. [ cited 2020 Jul 10]. Available from: https://www.copdfoundation.org/Downloads/COVID19_Webinar_Q_&_A_FINAL.pdf.
- D’Antiga L. Coronaviruses and Immunosuppressed Patients: the Facts During the Third Epidemic. Liver Transpl. 2020;26(6):832–834.
- Wong AW, Fidler L, Marcoux V. Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the COVID-19 Pandemic. Chest [Internet]. 2020 [ cited 2020 Jul 20]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194738/.
- Cuerpo S, Moisés J, Hernández-González F. Acute exacerbations of idiopathic pulmonary fibrosis: does clinical stratification or steroid treatment matter? Chron Respir Dis [Internet]. 2019 [ cited 2020 Jul 20]; 16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704413/.
- **CDC. Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention. 2020 [ cited 2020 Oct 28]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html.
- Use of chest imaging in COVID-19 - A rapid advice guide [Internet]. 2020 [ cited 2020 Jul 9]. Available from: https://www.who.int/publications-detail-redirect/use-of-chest-imaging-in-covid–19.
- Hare SS, Rodrigues JCL, Nair A. The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update. Clin Radiol. 2020;75(6):399–404.
- WHO COVID-19 Case definition [Internet]. [ cited 2020 Oct 29]. Available from: https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Surveillance_Case_Definition-2020.1.
- Diagnostic testing for SARS-CoV-2 [Internet]. [ cited 2020 Oct 28]. Available from: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov–2.
- Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays [Internet]. [ cited 2020 Oct 28]. Available from: https://www.who.int/publications-detail-redirect/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays.
- Knight SR, Ho A, Pius R. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ [Internet]. 2020 [ cited 2020 Oct 27]; 370. Available from: https://www.bmj.com/content/370/bmj.m3339.
- External validation of the 4C mortality score in the COVIDAge cohort of very old patients. 2020 [ cited 2020 Oct 27]; Available from: https://www.bmj.com/content/370/bmj.m3339/rr–10.
- **WHO. Clinical management of COVID-19 [Internet]. [ cited 2020 Jul 25]. Available from: https://www.who.int/publications-detail-redirect/clinical-management-of-covid–19.
- Carter C, Aedy H, Notter J. COVID-19 disease: non-Invasive Ventilation and high frequency nasal oxygenation. Clinics in Integrated Care. 2020;1:100006.
- Agarwal A, Basmaji J, Muttalib F. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission. Can J Anaesth. 2020;67(9):1–32.
- World Health Organization. Clinical management of COVID-19 - Interim Guidance [Internet]. 2020 [ cited 2020 Jul 20]. Available from: https://www.who.int/publications/i/item/clinical-management-of-covid–19.
- Poston JT, Patel BK, Davis AM. Management of Critically Ill Adults With COVID-19. JAMA. 2020;323:1839–1841.
- Roca O, Caralt B, Messika J. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019;199(11):1368–1376.
- Cook TM, El‐Boghdadly K, McGuire B. Consensus guidelines for managing the airway in patients with COVID-19. Anaesthesia. 2020;75(6):785–799.
- **MoHFW. Clinical Management Protocol : COVID - 19 [Internet]. [ cited 2020 Jul 25]. Available from: https://www.mohfw.gov.in/pdf/UpdatedClinicalManagementProtocolforCOVID19dated03072020.pdf.
- Montenegro F, Unigarro L, Paredes G. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review. Expert Rev Respir Med. 2020;0:null.
- Shekar K, Badulak J, Peek G. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers. Asaio J. 2020;66(7):707–721.
- Barbaro RP, MacLaren G, Boonstra PS. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071–1078.
- Coperchini F, Chiovato L, Croce L. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32.
- Soy M, Keser G, Atagündüz P. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020;39(7):2085–2094.
- Wu C, Chen X, Cai Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943.
- Wang Y, Jiang W, He Q. Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19 pneumonia: single-center experience from Wuhan, China [Internet]. Infectious Diseases (except HIV/AIDS); 2020 [cited 2020 Jul 10]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.03.06.20032342.
- Fadel R, Morrison A, Vahia A. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19. medRxiv. 2020;2020(05):04.20074609.
- Fang X, Mei Q, Yang T. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19. J Infect. 2020;81:147–178.
- Iacobucci G. Sixty seconds on … the RECOVERY trial. BMJ [Internet]. 2020 [ cited 2020 Jul 12]; 369. Available from: https://www.bmj.com/content/369/bmj.m1573.
- The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — preliminary Report. New England Journal of Medicine [Internet]. 2020 [ cited 2020 Jul 18]; Available from: http://www.nejm.org/doi/10.1056/NEJMoa2021436.
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro | Cell Research [Internet]. [ cited 2020 Jul 10]. Available from: https://www.nature.com/articles/s41422-020-0282–0.
- Beigel JH, Tomashek KM, Dodd LE. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020. 10.1056/NEJMoa2007764
- US FDA. Remdesivir letter of EUA [Internet]. [ cited 2020 Jul 10]. Available from: https://www.fda.gov/media/137564/download.
- Ranucci M, Ballotta A, Di Dedda U. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18(7):1747–1751.
- Maier CL, Truong AD, Auld SC. COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Lancet. 2020;395(10239):1758–1759.
- Varga Z, Flammer AJ, Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418.
- Al-Ani F, Chehade S, Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A Scoping Review Thromb Res. 2020;192:152–160.
- Rapkiewicz AV, Mai X, Carsons SE. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. EClinicalMedicine [Internet]. 2020 [ cited 2020 Jul 23]; 0. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30178-4/abstract.
- Carsana L, Sonzogni A, Nasr A. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. The Lancet Infectious Diseases [Internet]. 2020 [ cited 2020 Jul 23]; 0. Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30434-5/abstract.
- Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med. 2020;76:97–99.
- Wang D, Hu B, Hu C. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069.
- Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033–2040.
- Tang N, Li D, Wang X. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844–847.
- Tang N, Bai H, Chen X. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099.
- Moores LK, Tritschler T, Brosnahan S. Prevention, Diagnosis, and Treatment of VTE in Patients With COVID-19: CHEST Guideline and Expert Panel Report. CHEST [Internet]. 2020 [ cited 2020 Jul 23]; 0. Available from: https://journal.chestnet.org/article/S0012-3692(20)31625-1/abstract.
- Barnes GD, Burnett A, Allen A. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72–81.
- COVID-19 and VTE-Anticoagulation - Hematology.org [Internet]. [ cited 2020 Jul 23]. Available from: https://www.hematology.org:443/covid-19/covid-19-and-vte-anticoagulation.
- Huttner BD, Catho G, Pano-Pardo JR. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26(7):808–810.
- FRANCISCO EM. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19 [Internet]. European Medicines Agency. 2020 [ cited 2020 Oct 27]. Available from: https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid–19.
- The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19 [Internet]. [ cited 2020 Oct 27]. Available from: https://www.who.int/publications/i/item/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid–19.
- 5 Managing fever | COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community | Guidance | NICE [Internet]. NICE; [ cited 2020 Oct 27]. Available from: https://www.nice.org.uk/guidance/ng163/chapter/5-Managing-fever.
- Gupta A, Madhavan MV, Sehgal K. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017–1032.
- Edelson DP, Sasson C, Chan PS. Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: from the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association. Circulation [Internet]. 2020 [ cited 2020 Oct 27]; 141. Available from: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047463.
- Choi H, Qi X, Yoon SH. Extension of Coronavirus Disease 2019 (COVID-19) on Chest CT and Implications for Chest Radiograph Interpretation. Radiology. 2020;2:e200107.
- Ippolito D, Maino C, Pecorelli A. Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals. Respir Med. 2020;170:106036.
- Guan W, Ni Z, Hu Y. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
- Wong HYF, Lam HYS, Fong AH-T. Frequency and Distribution of Chest Radiographic Findings in COVID-19 Positive Patients. Radiology. 2020;296(2):201160.)
- Zu ZY, Jiang MD, Xu PP. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020;296(2)200490.
- Bernheim A, Mei X, Huang M. Chest CT Findings in Coronavirus Disease-19 (COVID-19): relationship to Duration of Infection. Radiology. 2020;3:200463. 10.1148/radiol.2020200463
- Kim H, Hong H, Yoon SH. Diagnostic Performance of CT and Reverse Transcriptase-Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis | radiology [Internet]. [ cited 2020 Jul 9]. Available from: https://pubs.rsna.org/doi/10.1148/radiol.2020201343.
- Muhammad SZ, Ahmed A, Shahid I. Chest computed tomography findings in hospitalized COVID-19 patients: a systematic review and meta-analysis. Infez Med. 2020;28:295–301.
- Iodice V, Pisaturo M, Fusco FM. Use of lung ultrasound in COVID-19: comparison with ultra-high-resolution computed tomography among 29 patients at “D. Cotugno” hospital, Naples, Italy. Infez Med. 2020;28:346–350.
- Management of COVID-19 | Coronavirus Disease COVID-19 [Internet]. COVID-19 Treatment Guidelines. [cited 2020 Jul 26]. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/management-of-covid-19
- Huang Y, Wang S, Liu Y. A Preliminary Study on the Ultrasonic Manifestations of Peripulmonary Lesions of Non-Critical Novel Coronavirus Pneumonia (COVID-19) [Internet]. Rochester, NY: Social Science Research Network; 2020 [ cited 2020 Apr 19]. Report No.: ID 3544750. Available from: https://papers.ssrn.com/abstract=3544750.
- Peng Q-Y, Wang X-T, Zhang L-N . Findings of lung ultrasonography of novel corona virus pneumonia during the 2019–2020 epidemic. Intensive Care Med [Internet]. 2020 [cited 2020 Apr 19]; Available from: https://doi.org/10.1007/s00134-020-05996-6.
- Volpicelli G, Gargani L. Sonographic signs and patterns of COVID-19 pneumonia. Ultrasound J. 2020;12(1):22.
- Xing C, Li Q, Du H. Lung ultrasound findings in patients with COVID-19 pneumonia. Crit Care. 2020;24(1):1–3.
- Trauer M, Matthies A, Mani N. Utility of Lung Ultrasound in COVID-19: A Systematic Scoping Review [Internet]. Emergency Medicine; 2020 [ cited 2020 Jul 9]. Available from: http://medrxiv.org/lookup/doi/10.1101/2020.06.15.20130344.
- Antithrombotic Therapy | Coronavirus Disease COVID-19 [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 18]. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/antithrombotic-therapy/.
- Remdesivir | Coronavirus Disease COVID-19 [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 18]. Available from: https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/remdesivir/.
- Immunomodulators | Coronavirus Disease COVID-19 [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 18]. Available from: https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/.
- Coronavirus » Interim Clinical Commissioning Policy: Remdesivir for patients hospitalised with COVID-19 (adults and children 12 years and older) [Internet]. [ cited 2020 Jul 18]. Available from: https://www.england.nhs.uk/coronavirus/publication/interim-clinical-commissioning-policy-remdesivir-for-patients-hospitalised-with-covid-19-adults-and-children-12-years-and-older/.
- Dexamethasone and COVID-19 [Internet]. SPS - Specialist Pharmacy Service. [ cited 2020 Jul 18]. Available from: https://www.sps.nhs.uk/articles/dexamethasone-and-covid–19/.
- CAS-ViewAlert [Internet]. [ cited 2020 Jul 18]. Available from: https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103054.
- Directorate General of Health Services M of H and FW Govt of India. Clinical Management Protocol for COVID19 [Internet]. 2020 [ cited 2020 Jul 10]. Available from: https://www.mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19dated27062020.pdf.
- Lombardy Section Italian Society Infectious And Tropical Diseases -. Vademecum for the treatment of people with COVID-19. Edition 2.0, 2020 Mar 13. Infez Med. 2020;28(2);143–152.
- Glenmark approved to supply favipiravir as COVID-19 treatment in India [Internet]. European Pharmaceutical Review. [ cited 2020 Jul 20]. Available from: https://www.europeanpharmaceuticalreview.com/news/121787/glenmark-approved-to-supply-favipiravir-as-covid-19-treatment-in-india/.
- Glenmark Pharmaceuticals. Glenmark becomes the first pharmaceutical company in India to receive regulatory approval for oral antiviral Favipiravir, for the treatment of mild to moderate COVID-19 [Internet]. 2020 [ cited 2020 Jul 12]. Available from: https://www.glenmarkpharma.com/sites/default/files/Glenmark-becomes-the-first-pharmaceut-cal-company-in-India-to-receive.pdf.
- DCGI Approves Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients [Internet]. News18. 2020 [ cited 2020 Jul 12]. Available from: https://www.news18.com/news/india/dcgi-approves-restricted-use-of-favipiravir-for-coronavirus-patients-2677649.html.
- NIH. Interleukin-6 Inhibitors [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 25]. Available from: https://www.covid19treatmentguidelines.nih.gov/immune-based-therapy/immunomodulators/interleukin-6-inhibitors/.
- ICTRP Search Portal [Internet]. [ cited 2020 Jul 19]. Available from: https://apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR2000029768.
- MD SC. Use of Ascorbic Acid in Patients With COVID 19 [Internet]. clinicaltrials.gov; 2020 [ cited 2020 Jul 16]. Report No.: NCT04323514. Available from: https://clinicaltrials.gov/ct2/show/NCT04323514.
- Vitamin C | Coronavirus Disease COVID-19 [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 19]. Available from: https://www.covid19treatmentguidelines.nih.gov/adjunctive-therapy/vitamin-c/.
- Carlucci P, Ahuja T, Petrilli CM. Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients. medRxiv. 2020;2020(05):02.20080036.
- IRCCS Sacro Cuore Don Calabria di Negrar. COVidIVERmectin: ivermectin for Treatment of Covid-19 [Internet]. [ cited 2020 Jul 20]. Available from: https://clinicaltrials.gov/ct2/show/NCT04438850.
- Chloroquine or Hydroxychloroquine | Coronavirus Disease COVID-19 [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 23]. Available from: https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine/.
- NIH. Hydroxychloroquine plus Azithromycin [Internet]. COVID-19 Treatment Guidelines. [ cited 2020 Jul 25]. Available from: https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/hydroxychloroquine-plus-azithromycin/.